Target intelligence / Profile preview

Contact sensitizer

Molecular classification
Other
01

Overview

A contact sensitizer is a chemical substance, typically a low-molecular-weight hapten, that possesses the potential to induce an allergic immune response upon skin contact (Martin SF, 2012; PMID: 22612390). These molecules are generally not immunogenic in their native state but acquire immunogenicity by covalently binding to endogenous skin proteins to form hapten-protein complexes (Kimber I, et al., 2018; PMID: 29550844). This process initiates the sensitization phase of allergic contact dermatitis (ACD), where dendritic cells process the complexes and present them to T lymphocytes in regional lymph nodes. Upon subsequent exposure, a rapid inflammatory response is triggered, leading to the clinical symptoms of ACD, such as erythema and edema (StatPearls, 2023; NBK441867). In the pharmaceutical and cosmetic industries, identifying contact sensitizers is a mandatory component of safety assessment to prevent occupational and consumer health risks (OECD, 2010; Test No. 429). Common examples include nickel, formaldehyde, and various fragrance allergens, which are screened using both in vivo assays like the Local Lymph Node Assay (LLNA) and modern in vitro alternatives.

Other names
Skin sensitizerHaptenContact allergen
02

Mechanism of action

Not applicable as this is a class of allergens rather than a therapeutic target.

03

Biological functions

Immune responseHypersensitivityProtein bindingT-cell activation
04

Disease associations

Allergic contact dermatitisInflammationEczema
05

Safety considerations

Induction of Type IV hypersensitivityChronic skin inflammationOccupational health hazardsSystemic sensitization
06

Biomarkers

CD86 expressionCD54 expressionIL-18 secretionNrf2-ARE activation (KeratinoSens)Cysteine reactivity (DPRA)

Beyond the preview

Go deeper on Contact sensitizer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contact sensitizer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call